<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://powerbase.info/index.php?action=history&amp;feed=atom&amp;title=Baxter_International</id>
	<title>Baxter International - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://powerbase.info/index.php?action=history&amp;feed=atom&amp;title=Baxter_International"/>
	<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Baxter_International&amp;action=history"/>
	<updated>2026-08-12T19:06:20Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.35.14</generator>
	<entry>
		<id>https://powerbase.info/index.php?title=Baxter_International&amp;diff=237125&amp;oldid=prev</id>
		<title>Matthew Pringle: /* Controversies */</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Baxter_International&amp;diff=237125&amp;oldid=prev"/>
		<updated>2016-07-11T16:01:31Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Controversies&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left diff-editfont-monospace&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 16:01, 11 July 2016&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot; &gt;Line 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Controversies==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Controversies==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Tax Evasion and Lobbying===&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Tax Evasion and Lobbying===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In December 2011, the non-partisan organization [[Public Campaign]] criticized Baxter for spending $10.45 million on lobbying and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million.&amp;lt;ref&amp;gt;Ashley Portero, [http://www.webcitation.org/64D9GyQG0 '30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010', ''International Business Times''. Archived from the original on December 26, 2011. Last accessed 11 July 2016.&amp;lt;/ref&amp;gt; The full Public Campaign report 'For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes' can be viewed [http://publicampaign.org/sites/default/files/ReportTaxDodgerLobbyingDec6.pdf here].&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;In December 2011, the non-partisan organization [[Public Campaign]] criticized Baxter for spending $10.45 million on lobbying and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million.&amp;lt;ref&amp;gt;Ashley Portero, [http://www.webcitation.org/64D9GyQG0 '30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010'&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;]&lt;/ins&gt;, ''International Business Times''. Archived from the original on December 26, 2011. Last accessed 11 July 2016.&amp;lt;/ref&amp;gt; The full Public Campaign report 'For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes' can be viewed [http://publicampaign.org/sites/default/files/ReportTaxDodgerLobbyingDec6.pdf here].&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==People==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==People==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Matthew Pringle</name></author>
	</entry>
	<entry>
		<id>https://powerbase.info/index.php?title=Baxter_International&amp;diff=237124&amp;oldid=prev</id>
		<title>Matthew Pringle: page created</title>
		<link rel="alternate" type="text/html" href="https://powerbase.info/index.php?title=Baxter_International&amp;diff=237124&amp;oldid=prev"/>
		<updated>2016-07-11T16:00:58Z</updated>

		<summary type="html">&lt;p&gt;page created&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Overview==&lt;br /&gt;
&lt;br /&gt;
Baxter International is an American healthcare company based in Deerfield, Illinois, USA&amp;lt;ref&amp;gt;[http://investor.baxter.com/phoenix.zhtml?c=86121&amp;amp;p=irol-contact Baxter contact info], Baxter website, accessed 11 July 2016.&amp;lt;/ref&amp;gt; .It was founded in 1931, and as of July 2016 employs over 10,000 staff.&amp;lt;ref&amp;gt;[https://www.linkedin.com/company/baxter-healthcare Baxter International], Baxter LinkedIn page, accessed 11 July 2016.&amp;lt;/ref&amp;gt; The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Baxter has two global business units: Hospital Products and Renal.&amp;lt;ref&amp;gt;[http://www.baxter.com/inside-baxter/about/overview/corporate.page? 'Corporate Overview'], Baxter International, accessed 11 July 2016.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Controversies==&lt;br /&gt;
===Tax Evasion and Lobbying===&lt;br /&gt;
In December 2011, the non-partisan organization [[Public Campaign]] criticized Baxter for spending $10.45 million on lobbying and not paying any taxes during 2008–2010, instead getting $66 million in tax rebates, despite making a profit of $926 million.&amp;lt;ref&amp;gt;Ashley Portero, [http://www.webcitation.org/64D9GyQG0 '30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010', ''International Business Times''. Archived from the original on December 26, 2011. Last accessed 11 July 2016.&amp;lt;/ref&amp;gt; The full Public Campaign report 'For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes' can be viewed [http://publicampaign.org/sites/default/files/ReportTaxDodgerLobbyingDec6.pdf here].&lt;br /&gt;
&lt;br /&gt;
==People==&lt;br /&gt;
Key people at Baxter, as listed on www.baxter.com. Correct as of 11 July 2016.&amp;lt;ref&amp;gt;[http://www.baxter.com/inside-baxter/about/leadership.page?scroll=tab-navigation Company Leadership], Baxter International website, accessed 11 July 2011.&amp;lt;/ref&amp;gt;&lt;br /&gt;
===Board of Directors===&lt;br /&gt;
*[[José Almeida]] - Chairman and Chief Executive Officer, Baxter International Inc.&lt;br /&gt;
*[[Thomas Chen]] - Former Senior Vice President and President, International Nutrition, [[Abbott Laboratories]].&lt;br /&gt;
*[[Uma Chowdhry]] -Former Senior Vice President and Chief Science and Technology Officer, [[DuPont|E.I. DuPont de Nemours &amp;amp; Company]].&lt;br /&gt;
*[[John Forsyth]] - Chairman and Chief Executive Officer, [[Wellmark Blue Cross and Blue Shield]].&lt;br /&gt;
*[[James R. Gavin III]] - Chief Executive Officer and Chief Medical Officer, [[Healing Our Village]], Inc.&lt;br /&gt;
*[[Peter Hellman]] - Former President, Chief Financial and Administrative Officer, [[Nordson Corporation]].&lt;br /&gt;
*[[Munib Islam]] - Partner and Head of Equities Research, [[Third Point]] LLC.&lt;br /&gt;
*[[Michael Mahoney]] - Chairman, President and Chief Executive Officer, [[Boston Scientific Corporation]].&lt;br /&gt;
*[[Carole Shapazian]] - Former Executive Vice President, [[Maytag Corporation]].&lt;br /&gt;
*[[Thomas Stallkamp]] - Lead Director and Founder and Principal, [[Collaborative Management]] LLC.&lt;br /&gt;
*[[K. J. Storm]] - Former Chairman of the Executive Board, [[AEGON N.V.]] (The Netherlands).&lt;br /&gt;
*[[Albert Stroucken]] - Former Executive Chairman and Chief Executive Officer, [[Owens-Illinois]], Inc.&lt;br /&gt;
&lt;br /&gt;
===Executive Officers===&lt;br /&gt;
*[[osé Almeida]] - Chairman of the Board and Chief Executive Officer.&lt;br /&gt;
*[[Brik Eyre]] - Corporate Vice President and President, Hospital Products.&lt;br /&gt;
*[[Robert Felicelli]] - Corporate Vice President, Business Transformation.&lt;br /&gt;
*[[Jeanne Mason]] - Corporate Vice President, Human Resources.&lt;br /&gt;
*[[James Saccaro]] - Corporate Vice President and Chief Financial Officer.&lt;br /&gt;
*[[Marcus Schabacker]] - Corporate Vice President and Chief Scientific Officer.&lt;br /&gt;
*[[David Scharf]] - Corporate Vice President and General Counsel.&lt;br /&gt;
*[[Paul Vibert]] - Corporate Vice President and President, International.&lt;br /&gt;
&lt;br /&gt;
===Corporate Officers===&lt;br /&gt;
*[[Scott Bohaboy]] - Corporate Vice President, Treasurer and Head of Global Planning.&lt;br /&gt;
*[[Caroline Karp]] - Corporate Vice President and Controller.&lt;br /&gt;
*[[Paul Martin]] - Corporate Vice President and Chief Information Officer.&lt;br /&gt;
*[[Ellen McKintosh]] - Corporate Vice President, Associate General Counsel and Corporate Secretary.&lt;br /&gt;
&lt;br /&gt;
==Affiliations==&lt;br /&gt;
*[[Baxalta]] - Founded on 1 July 2015 after its parent company, Baxter International, spun off the biopharmaceutical division.&amp;lt;ref&amp;gt;[http://cnafinance.com/baxalta-a-rare-undervalued-biopharmaceutical-company/4870 'Baxalta: A Rare Undervalued Biopharmaceutical Company'], ''CNA Finance'', 23 July 2015.&amp;lt;/ref&amp;gt; [[Baxalta]] merged with [[Shire]] in a $32 billion deal in January 2016.&amp;lt;ref&amp;gt;[http://www.genengnews.com/gen-news-highlights/shire-baxalta-tie-the-knot-in-32b-merger/81252213/ 'Shire, Baxalta Tie the Knot in $32B Merger'], ''GEN - Genetic Engineering &amp;amp; Biotechnology News'', 11 January 2016.&amp;lt;/ref&amp;gt;&lt;br /&gt;
==Science Media Centre donor==&lt;br /&gt;
Baxter is a former donor to the [[Science Media Centre]] according to the SMC website.&amp;lt;ref&amp;gt;[http://www.sciencemediacentre.org/about-us/funding/ Science Media Centre funding], Science Media Centre website, accessed 11 July 2011.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Contact==&lt;br /&gt;
:Corporate Headquarters&lt;br /&gt;
:Baxter International Inc. &lt;br /&gt;
:One Baxter Parkway &lt;br /&gt;
:Deerfield, IL 60015 &lt;br /&gt;
:Telephone: (224)948-2000&lt;br /&gt;
:www.baxter.com&lt;br /&gt;
&lt;br /&gt;
==Resources==&lt;br /&gt;
*[http://www.baxter.com/index.page Baxter International website].&lt;br /&gt;
*[[Public Campaign]] report - [http://publicampaign.org/sites/default/files/ReportTaxDodgerLobbyingDec6.pdf For Hire: Lobbyists or the 99%? How Corporations Pay More for Lobbyists Than in Taxes.]&lt;br /&gt;
&lt;br /&gt;
==Notes==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Healthcare Industry]][[Category:Transnational Corporations]][[Category:Science Media Centre]]&lt;/div&gt;</summary>
		<author><name>Matthew Pringle</name></author>
	</entry>
</feed>